Live attenuated rubella virus vaccines prepared in duck embryo cell culture. II. Clinical tests in families and in an institution.

R. Weibel,J. Stokes,E. Buynak,J. Whitman,M. B. Leagus,M. Hilleman

DOI: https://doi.org/10.1001/JAMA.1968.03140340024005

1968-08-19

Abstract:Duck embryo cell culture rubella virus vaccines prepared with the HPV-77 (Meyer-Parkman) and the Merck (B-level attenuation) strains of virus were evaluated in a large-scale family study in the open community and in an institution. Of 265 initially seronegative children vaccinated with the HPV-77 virus in duck embryo cell culture, 97% responded serologically with a geometric mean hemagglutination-inhibiting (HI) titer of 1:53.2. There was no apparent clinical illness and no serologic evidence for contact spread to 262 susceptible siblings or to 34 maternal contacts. The performance of the Merck B-level vaccine in duck embryo cell culture in the smaller institutional study was essentially the same as that of the HPV-77 except that the mean HI titer was almost three times as great (1:148.3). Both vaccines proved safe and efficacious in children, and community studies are in progress in larger numbers of persons.